• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】36984

【品名】benzyl 6-oxo-5,6,7,8-tetrahydro-2-naphthalenylcarbamate

【CA登记号】

【 分 子 式 】C18H17NO3

【 分 子 量 】295.33792

【元素组成】C 73.2% H 5.8% N 4.74% O 16.25%

与该中间体有关的原料药合成路线共 2 条

合成路线1

该中间体在本合成路线中的序号:(XII)

A new process for the preparation of emtricitabine has been described: The esterification of 2-butene-1,4-diol (I) with butyryl chloride and DMAP in pyridine gives the diester (II), which by ozonolysis with O3 in methanol provides the hemiacetal (III). Cyclization of (III) with 2-mercaptoacetic acid in refluxing toluene affords racemic 2-(butyryloxymethyl)-1,3-oxathiolan-5-one (V), which is submitted to optical resolution to afford the (R)-enantiomer (VI). The reduction of (VI) with Li(t-BuO)3AlH, followed by acetylation with acetic anhydride gives 5-(acetoxy)-2(R)-(butyryloxy)-1,3-oxathiolane (VII), which by treatment with HCl in dichloroethane is converted into 2(R)-(butyryloxy)-5-chloro-1,3-oxathiolane (VIII). Condensation of (VIII) with 5-fluoro-bis(trimethylsilyl)cytosine (IX) ­ obtained by silylation of cytosine (X) with HMDS ­ by means of NaHCO3 in dichloroethane gives a diastereomeric mixture of the butyrate nucleosides (XI), which is hydrolyzed with butylamine in methanol yielding the corresponding diastereomeric mixture of the (2R,5S)-isomer, emtricitabine, and the (2R,5R)-isomer (XII). This mixture is separated by crystallization of the corresponding hydrochlorides obtained by treatment with HCl in methanol/dioxane.

1 Almond, M.; Painter, G.R.; Liotta, D.C.; Cleary, D.; Soria, J. (Emory University; Triangle Pharmaceuticals, Inc.); Method of manufacture of 1,3-oxathiolane nucleosides. WO 0009494 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 36965 (Z)-2-butene-1,4-diol 6117-80-2 C4H8O2 详情 详情
(II) 36966 (Z)-4-(butyryloxy)-2-butenyl butyrate C12H20O4 详情 详情
(III) 39681 2-hydroxy-2-methoxyethyl butyrate C7H14O4 详情 详情
(IV) 18524 2-sulfanylacetic acid 68-11-1 C2H4O2S 详情 详情
(V) 36968 (5-oxo-1,3-oxathiolan-2-yl)methyl butyrate C8H12O4S 详情 详情
(VI) 39682 [(2R)-5-oxo-1,3-oxathiolan-2-yl]methyl butyrate C8H12O4S 详情 详情
(VII) 39683 [(2R)-5-(acetoxy)-1,3-oxathiolan-2-yl]methyl butyrate C10H16O5S 详情 详情
(VIII) 39685 [(2R)-5-chloro-1,3-oxathiolan-2-yl]methyl butyrate C8H13ClO3S 详情 详情
(IX) 36959 5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine C10H20FN3OSi2 详情 详情
(X) 16747 4-amino-5-fluoro-2(1H)-pyrimidinone; 5-fluorocytosine 2022-85-7 C4H4FN3O 详情 详情
(XI) 36970 (rac)-[(2R,5S)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl butyrate C12H16FN3O4S 详情 详情
(XII) 36984 benzyl 6-oxo-5,6,7,8-tetrahydro-2-naphthalenylcarbamate C18H17NO3 详情 详情

合成路线2

该中间体在本合成路线中的序号:(V)

Tetralone (I) was reduced with NaBH4 and the resulting alcohol (II) was dehydrated with p-TsOH in refluxing toluene to yield the dihydronaphthalene (III). Oxidation of (III) with N-methylmorpholine N-oxide and OsO4 produced diol (IV), which was converted to the 2-tetralone (V) by acid-catalyzed rearrangement. The unstable tetralone (V) was condensed with the sodium salt of tert-butyl diethyl phosphonoacetate (VI) providing a mixture of olefin isomers (VII). Catalytic hydrogenation of the olefin (VIIa-c) with simultaneous removal of the carbobenzoxy group furnished the aminotetralin (VIII). This was coupled with 4-cyanobenzoic acid (IX) using EDC to give amide (X). Addition of H2S to the nitrile group of (X), followed by S-methylation provided (XI). Then, displacement of the methylthio group of (XI) by ammonium acetate and further treatment with di-tert-butyl dicarbonate yielded the Boc-protected benzamidine (XII). Deprotection with trifluoroacetic acid produced the amidino acid (XIII), which was finally esterified with EtOH and HCl.

1 Fisher, M.J.; Arfstan, A.E.; Giese, U.; et al.; Fused bicyclic Gly-Asp beta-turn mimics with specific affinity for GPIIb-IIIa. J Med Chem 1999, 42, 23, 4875.
2 Fisher, M.J.; Happ, A.M.; Jakubowski, J.A.; Kinnick, M.D.; Kline, A.D.; Morin, J.M. Jr.; Sall, D.J.; Skelton, M.A.; Vasileff, R.T. (Eli Lilly and Company); Glycoprotein IIb/IIIa antagonists. CA 2128348; EP 0635492; JP 1996188564; US 5618843 .
3 Fisher, M.J.; Jakubowski, J.A.; Martinelli, M.J.; Morin, J.M. Jr.; Paal, M.; Ruhter, G.; Ruterbories, K.J.; Schotten, T.; Stenzel, W.; Vasileff, R.T. (Eli Lilly and Company); Glycoprotein IIb/IIIa antagonists. EP 0804431; JP 1999502194; WO 9622288 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VIIa) 36985 tert-butyl 2-(6-[[(benzyloxy)carbonyl]amino]-1,2,3,4-tetrahydro-2-naphthalenyl)acetate C24H29NO4 详情 详情
(VIIb) 36986 (E)-tert-butyl 2-[6-[[(benzyloxy)carbonyl]amino]-3,4-dihydro-2(1H)-naphthalenylidene]acetate C24H27NO4 详情 详情
(VIIc) 36987 (Z)-tert-butyl 2-[6-[[(benzyloxy)carbonyl]amino]-3,4-dihydro-2(1H)-naphthalenylidene]acetate C24H27NO4 详情 详情
(I) 36980 benzyl 5-oxo-5,6,7,8-tetrahydro-2-naphthalenylcarbamate C18H17NO3 详情 详情
(II) 36981 benzyl 5-hydroxy-5,6,7,8-tetrahydro-2-naphthalenylcarbamate C18H19NO3 详情 详情
(III) 36982 benzyl 7,8-dihydro-2-naphthalenylcarbamate C18H17NO2 详情 详情
(IV) 36983 benzyl 5,6-dihydroxy-5,6,7,8-tetrahydro-2-naphthalenylcarbamate C18H19NO4 详情 详情
(V) 36984 benzyl 6-oxo-5,6,7,8-tetrahydro-2-naphthalenylcarbamate C18H17NO3 详情 详情
(VI) 25637 tert-butyl 2-(diethoxyphosphoryl)acetate 6273-47-8 C10H21O5P 详情 详情
(VIII) 36988 tert-butyl 2-(6-amino-1,2,3,4-tetrahydro-2-naphthalenyl)acetate C16H23NO2 详情 详情
(IX) 36897 4-cyanobenzoic acid;4-Carboxybenzonitrile;p-Carboxybenzonitrile 619-65-8 C8H5NO2 详情 详情
(X) 36989 tert-butyl 2-[6-[(4-cyanobenzoyl)amino]-1,2,3,4-tetrahydro-2-naphthalenyl]acetate C24H26N2O3 详情 详情
(XI) 36990 tert-butyl 2-[6-([4-[imino(methylsulfanyl)methyl]benzoyl]amino)-1,2,3,4-tetrahydro-2-naphthalenyl]acetate C25H30N2O3S 详情 详情
(XII) 36991 tert-butyl 2-[6-([4-[[(tert-butoxycarbonyl)amino](imino)methyl]benzoyl]amino)-1,2,3,4-tetrahydro-2-naphthalenyl]acetate C29H37N3O5 详情 详情
(XIII) 36992 2-[6-([4-[amino(imino)methyl]benzoyl]amino)-1,2,3,4-tetrahydro-2-naphthalenyl]acetic acid C20H21N3O3 详情 详情
Extended Information